SCHEMBL7608314

SCHEMBL7608314

COCCn1c(=O)c2c(ncn2Cc2ccccc2)n(C2CC2)c1=O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.56
MEN1 O00255 2/20 0.56
POLB P06746 2/20 0.56
HIF1A Q16665 1/20 0.56
SMN1; SMN2 Q16637 3/20 0.53
ADORA2B P29275 1/20 0.53
RXFP1 Q9HBX9 1/20 0.53
LMNA P02545 3/20 0.50
THRB P10828 1/20 0.50
NPSR1 Q6W5P4 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
ALDH1A1 P00352 2/20 0.49
PDE1A P54750 1/20 0.49
PDE1B Q01064 1/20 0.49
PDE1C Q14123 1/20 0.49
KDM4E B2RXH2 1/20 0.47
USP2 O75604 1/20 0.47
DCTPP1 Q9H773 1/20 0.46
MAPK1 P28482 2/20 0.46
HPGD P15428 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1947176 0.87 KMT2A (0.71) KMT2AMEN1POLBHIF1ASMN1; SMN2
SCHEMBL27387998 0.84 SMN1; SMN2 (0.71) POLBHIF1ASMN1; SMN2ADORA2BRXFP1
SCHEMBL555902 0.81 PDE1A (0.70) KMT2AMEN1POLBHIF1ASMN1; SMN2
SCHEMBL9842744 0.78 PDE5A (0.50) KMT2APOLBHIF1ARXFP1LMNA
SCHEMBL1945900 0.78 SMN1; SMN2 (0.55) KMT2AMEN1POLBHIF1ASMN1; SMN2
SCHEMBL7603086 0.78 KMT2A (0.62) KMT2AMEN1POLBHIF1ASMN1; SMN2
SCHEMBL7604892 0.77 KMT2A (0.61) KMT2AMEN1POLBHIF1ASMN1; SMN2
SCHEMBL9765078 0.76 PDE4A (0.50) POLBHIF1ASMN1; SMN2ADORA2BRXFP1
SCHEMBL7608305 0.75 POLB (0.75) KMT2AMEN1POLBHIF1ASMN1; SMN2
SCHEMBL7603804 0.75 POLB (0.67) KMT2AMEN1POLBHIF1ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0812844-B1 Use of theophyllin derivatives for the treatment and prophylaxis fo shock conditions, novel xanthine compounds and processes for the production thereof HOECHST AG (DE) 2002-10-23 EP disclosed
CN-1066146-C Use of theophylline derivatives for curing and preventing shock state, xanthine derivatives and preparation thereof AVENTIS PHARMACEUTICALS AG (DE) 2001-05-23 CN disclosed
US-6214992-B1 THEOPHYLLINE DERIVATIVES HAVING AT LEAST ONE ETHER FUNCTION IN METHYL RADICAL; XANTHINE COMPOUNDS WITH THIS SUBSTITUTION PATTERN USED AS ANTISHOCK TREATMENT HOECHST AKTIENGESELLSCHAFT (DE) 2001-04-10 US disclosed
CN-1169993-A Use of theophylline derivatives for curing and preventing shock state, xanthine derivatives and preparation thereof HOECHST AG (DE) 1998-01-14 CN disclosed
EP-0812844-A2 Use of theophyllin derivatives for the treatment and prophylaxis fo shock conditions, novel xanthine compounds and processes for the production thereof HOECHST AKTIENGESELLSCHAFT (DE) 1997-12-17 EP disclosed